Top companies and drugs by sales in 2023doi:10.1038/d41573-024-00041-3Paul VerdinNature Reviews Drug Discovery
2024年3月8日,Nat Rev Drug Discov发表文章Top companies and drugs by sales in 2023,介绍了2023年销售额最高的公司和药品。 以往年度的回顾文章参见 Nat Rev Drug Discov|2022年销售额排名Top10的制药公司和药品 Nat Rev Drug Discov|2021年制药公司和药物的销售额Top10 正如人们所预料的那样,2023年...
亲爱的鹰谷伙伴们,一路相伴,感恩有你~ 为回馈新老朋友对鹰谷的支持与信任,鹰谷为您精心准备了一份特别的礼物——Top200世界药物销售额前200排行榜(Top 200 Brand Name Drugs by Retails Sales in 2023)。海报数据选自美国亚利桑那大...
Market watch: Top drugs and companies by sales in 2017doi:10.1038/nrd.2018.42UrquhartLisaNature Reviews Drug DiscoveryUrquhart, L. Market watch: Top drugs and companies by sales in 2017. Nat. Rev. Drug Discov. 2018, 17, 232. [CrossRef] [PubMed]...
of branded drugsaccount for around 84 percent of the market. Drugs can be categorized in several ways, but a common method is to group them by what they are used to treating. In the United States, cancer, diabetes, and immunology are among theleading therapeutic categoriesbased on sales. ...
Pharmaceutical market: worldwide revenue 2001-2023 Top 50 pharmaceutical companies - Rx sales and R&D spending 2023 Top global biopharma drugs by lifetime sales up to 2028 Discover Statista Statista Search Statista Search Need help with using Statista for your research? Tutorials and first steps ...
While the global sales rankings of Big Pharma's superstar drugs naturally feature the biggest names in the business, new meds often pop up or old drugs exit the scene. And the moves within the list from year to year illustrate many of the trends shaping pharma on a daily basis. ...
These companies facilitate access to a wide array of therapeutic options, contributing significantly to the improvement of public health. Their vast R&D budgets, coupled with extensive clinical trials, have paved the way for numerous life-changing drugs that have revolutionised the treatment of various...
Looking ahead to 2024 and beyond, the pharma industry is set to face further shake-ups in the coming years with many more blockbuster drugs from Bristol Myers Squibb, Novartis and other companies are set to face their first generic or biosimilar competitors in the largest global pharma market,...
"Companies may choose not to track the presence of these ingredients/compounds due to concern about future litigation," the report said.Some additives can remain hidden from the public behind such catchall terms as "spices" and "artificial flavors," as the Center for Science in the Public ...